Stanley T Crooke

15PUBLICATIONS
30CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyGene and molecular therapyNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 21, 2026
Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy.

|Jun 02, 2026
Addressing the needs of nano-rare patients: the n-Lorem experience.

|Apr 14, 2026
Phosphorothioate antisense oligonucleotide induced innate immune activation is attenuated by tryptophan oxidation products.

Julia Pytte, Lesley Saldana, Wei Zhang

|Mar 02, 2026
Establishing a commercial solution for extremely rare genetic diseases.

Stanley T Crooke, Andrew W Lo

|Jul 17, 2025
Splice-modulating antisense oligonucleotides targeting a pathogenic intronic variant in adult polyglucosan body disease correct mis-splicing and restore enzyme activity in patient cells.

Ria Thomas, Emily Miyoshi, Hasan O Akman

|Aug 09, 2024
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder.

Alban Ziegler, Joanne Carroll, Jennifer M Bain

Pageof 3

Frequent Collaborators

5 joint publications

Xuehai Liang

2 joint publications

Konstantina Skourti-Stathaki

2 joint publications

Elizabeth Berry-Kravis

2 joint publications

Julia Pytte